Cormorant Asset Management, LP

Insider Buys Quantity –
21
2024-05-06PurchaseEyePoint Pharmaceuticals, Inc.
EYPT
10 percent owner
850,000
1.8064%
$11.86$10.08M-4.24%
2024-04-18PurchaseEyePoint Pharmaceuticals, Inc.
EYPT
10 percent owner
581,765
1.2029%
$18.03$10.49M-35.22%
2024-04-01SaleImmuneering Corporation
IMRX
10 percent owner
400,000
1.4407%
$2.90$1.16M-44%
2024-03-15SaleImmuneering Corporation
IMRX
10 percent owner
400,000
1.5312%
$2.14$856,400-18.32%
2024-03-14SaleImmuneering Corporation
IMRX
10 percent owner
509,091
1.0954%
$3.72$1.89M-46.21%
2024-01-11PurchaseEyePoint Pharmaceuticals, Inc.
EYPT
10 percent owner
750,000
2.0594%
$19.75$14.81M+2.4%
2024-01-09PurchaseEyePoint Pharmaceuticals, Inc.
EYPT
10 percent owner
105,000
0.2958%
$21.32$2.24M-3.03%
2023-12-08PurchaseEyePoint Pharmaceuticals, Inc.
EYPT
10 percent owner
588,235
1.4847%
$17.00$10M+9.04%
2023-12-04PurchaseEyePoint Pharmaceuticals, Inc.
EYPT
10 percent owner
1.92M
6.3418%
$21.82$41.87M+6.41%
2021-10-25PurchaseVentyx Biosciences, Inc.
VTYX
1.25M
8.2073%
$16.00$20M-16.24%
2021-10-13PurchasePyxis Oncology, Inc.
PYXS
450,000
1.9034%
$16.00$7.2M-70.72%
2021-09-17PurchaseTyra Biosciences, Inc.
TYRA
625,000
5.4808%
$16.00$10M-43.6%
2021-08-03PurchaseImmuneering Corporation
IMRX
550,000
2.3534%
$15.00$8.25M-47.84%
2021-07-02PurchaseAerovate Therapeutics, Inc.
AVTE
1M
2.9395%
$14.00$14M-34%
2021-06-29PurchaseElevation Oncology, Inc.
ELEV
250,000
30.0099%
$16.00$4M-56%
2021-06-28PurchaseMonte Rosa Therapeutics, Inc.
GLUE
600,000
11.7588%
$19.00$11.4M-7.95%
2021-06-21PurchaseVerve Therapeutics, Inc.
VERV
550,000
3.5535%
$19.00$10.45M-7.41%
2021-03-30PurchaseDesign Therapeutics, Inc.
DSGN
750,000
2.8822%
$20.00$15M-40.99%
2020-12-18PurchaseBioAtla, Inc.
BCAB
1.6M
2.4444%
$18.00$28.8M+17.46%
2020-11-23PurchaseOlema Pharmaceuticals, Inc.
OLMA
850,000
1.5181%
$19.00$16.15M-44.3%